ACE Report Cover
IV Dexamethasone offers postoperative pain reduction in femoral neck fracture fixation
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
BMC Anesthesiol
TRAUMA
IV Dexamethasone offers postoperative pain reduction in femoral neck fracture fixation .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2021;9(16):29

BMC Anesthesiol. 2016 Sep 22;16(1):79

Contributing Authors

S Szucs D Jessop G Iohom GD Shorten

37 patients, over the age of 65 years, with a femoral neck fracture who were scheduled for operative fixation, were randomized to a preoperative IV dose of either dexamethasone 0.1mh/kg or placebo. The purpose of this study was to determine if preoperative dexamethasone led to a significant reduction in pain and opioid consumption over the first 3 days and 1 week after surgery. Scores for pain at rest were significantly lower in the dexamethasone group compared to the placebo group at 6 hours, and morphine consumption within the first 24 hours was significantly lower in the dexamethasone group compared to the placebo group. The difference between groups in pain scores on movement did not reach significance, and no significant differences in either pain comparison were found at subsequent follow-up time points.


Publication Funding Details +
Funding:
Non-Industry funded
Sponsor:
Department of Anaesthesia, Intensive Care and Pain Medicine, Cork University Hospital
Conflicts:
None disclosed

Risk of Bias

8/10

Reporting Criteria

13/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

4/4

Randomization

3/4

Outcome Measurements

0/4

Inclusion / Exclusion

2/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

Femoral neck fractures are common among elderly patients presenting with trauma, necessitating surgical fixation. Preoperative low-dose dexamethasone has been suggested as a possible addition to multimodal analgesia regimens to improve postoperative analgesic efficacy. However, there have been concerns expressed relating to a possible increase in adverse events, particularly in such an age group.

What was the principal research question?

In the fixation of femoral neck fractures, does a preoperative IV dose of dexamethasone 0.1mg/kg result in significantly lower pain scores at 6 hours postoperatively when compared to placebo saline?

Study Characteristics +
Population:
37 patients, over the age of 65, with a femoral neck fracture who were scheduled for operative fixation. All procedures were performed under spinal anesthesia. Postoperative analgesia included intravenous paracetamol 1g every 6 hours, and intramuscular morphine 5-10mg for rescue analgesia.
Intervention:
Dexamethasone group: Within the operating room prior to surgery, patients were administered intravenously, dexamethasone 0.1mg/kg.
Comparison:
Placebo group: Within the operating room prior to surgery, patients were administered intravenously, placebo saline.
Outcomes:
The primary outcome measure was pain on a numeric rating scale (NRS; 0-10), both at rest and on movement. Secondary outcomes included analgesic consumption and incidence of nausea/vomiting, sedation, and pruritus.
Methods:
RCT
Time:
Patients were assessed at 6h (primary endpoint), 12h, 24h, 48h, 72h, and 1 week postoperatively.
What were the important findings?
  • At 6 hours, NRS pain at rest scores was significantly lower in the dexamethasone group (0.8+/-1.3) compared to the placebo group (3.9+/-2.9) (p=0.0004). The difference in NRS pain on movement between the dexamethasone group (3.2+/-2.6) and placebo group (5.5+/-3.8) did not reach statistical significance (p=0.055).
  • No significant differences between groups in NRS pain at rest or on movement were reported from 12h to 1 week postoperatively.
  • Cumulative 24h morphine consumption was significantly lower in the dexamethasone group (7.7+/-8.3mg) compared to the placebo group (15.1+/-9.4mg) (p=0.04).
  • The incidence of postoperative nausea/vomiting, sedation, and pruritus were reported to not significantly differ between groups.
What should I remember most?

In the operative fixation of a femoral neck fracture in those 65 years of age or older, the use of a preoperative dose of dexamethasone 0.1mg/kg demonstrated significantly reduced pain at rest for the first 6 hours after surgery, and significantly lower opioid consumption for the first 24 hours after surgery. Differences between groups at subsequent time points were not significant, nor was pain during movement at any time point.

How will this affect the care of my patients?

The results of this study suggest that an IV dose (0.1mg/kg) of dexamethasone prior to fixation of a femoral neck fracture may be beneficial for early pain management in older patients. Nevertheless, pain rebounded beyond 6 hours and was similar to placebo for the remainder of the follow-up period. Therefore, the use of a postoperative dexamethasone dose in multimodal analgesia regimens should be considered for investigation in future trials. Additionally, the sample size of the current study was quite small, limiting the strength of the obtained results. Larger trials are needed to confirm the findings of the current study.

DISCLAIMER

This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. IV Dexamethasone offers postoperative pain reduction in femoral neck fracture fixation. OE Journal. 2021;9(16):29. Available from: https://myorthoevidence.com/AceReport/Show/iv-dexamethasone-offers-postoperative-pain-reduction-in-femoral-neck-fracture-fixation

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report